MX2021011589A - Composición anestésica y método para anestesiar el ojo. - Google Patents
Composición anestésica y método para anestesiar el ojo.Info
- Publication number
- MX2021011589A MX2021011589A MX2021011589A MX2021011589A MX2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A
- Authority
- MX
- Mexico
- Prior art keywords
- articaine
- eye
- anesthetic
- formulation
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962824207P | 2019-03-26 | 2019-03-26 | |
PCT/US2019/024239 WO2019191200A1 (en) | 2018-03-27 | 2019-03-27 | Method and formulation for producing anesthesia of internal aspect of eye wall by topical application |
US16/811,798 US11096922B2 (en) | 2018-03-27 | 2020-03-06 | Anesthetic composition and method of anesthetizing the eye |
PCT/US2020/022915 WO2020197816A1 (en) | 2019-03-26 | 2020-03-16 | Anesthetic composition and method of anesthetizing the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021011589A true MX2021011589A (es) | 2021-12-15 |
Family
ID=72609654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021011589A MX2021011589A (es) | 2019-03-26 | 2020-03-16 | Composición anestésica y método para anestesiar el ojo. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3946311A4 (pt) |
JP (1) | JP2022527621A (pt) |
KR (1) | KR20210143254A (pt) |
CN (1) | CN114072139A (pt) |
AU (1) | AU2020245203A1 (pt) |
BR (1) | BR112021019039A2 (pt) |
CA (1) | CA3134531A1 (pt) |
IL (1) | IL286624A (pt) |
MX (1) | MX2021011589A (pt) |
SG (1) | SG11202110423UA (pt) |
WO (1) | WO2020197816A1 (pt) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3337218B2 (ja) * | 1992-05-06 | 2002-10-21 | アルコン ラボラトリーズ,インコーポレイテッド | 眼科用組成物におけるホウ酸塩−ポリオール複合体の使用 |
EP1480677B8 (en) * | 2001-11-21 | 2012-05-23 | Carl Zeiss Meditec SAS | Composition for stabilizing hyaluronic acid |
CN101695488B (zh) * | 2009-11-05 | 2012-05-02 | 蚌埠丰原涂山制药有限公司 | 复方阿替卡因注射用冻干制剂及其制备方法 |
CN101721407B (zh) * | 2009-11-23 | 2013-04-10 | 蚌埠丰原涂山制药有限公司 | 复方盐酸阿替卡因注射液及其制备方法 |
FR2968996B1 (fr) * | 2010-12-17 | 2013-04-12 | Anteis Sa | Formulation aqueuse injectable sterile utilisee en ophtalmologie |
FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
WO2017044659A1 (en) * | 2015-09-08 | 2017-03-16 | Viewpoint Therapeutics, Inc. | Compounds and formulations for treating ophthalmic diseases |
WO2018220283A1 (fr) * | 2017-05-29 | 2018-12-06 | Kh Medtech Sarl | Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine |
-
2020
- 2020-03-16 WO PCT/US2020/022915 patent/WO2020197816A1/en active Application Filing
- 2020-03-16 AU AU2020245203A patent/AU2020245203A1/en active Pending
- 2020-03-16 CN CN202080033483.9A patent/CN114072139A/zh active Pending
- 2020-03-16 EP EP20776365.7A patent/EP3946311A4/en active Pending
- 2020-03-16 MX MX2021011589A patent/MX2021011589A/es unknown
- 2020-03-16 JP JP2021560140A patent/JP2022527621A/ja active Pending
- 2020-03-16 BR BR112021019039A patent/BR112021019039A2/pt unknown
- 2020-03-16 CA CA3134531A patent/CA3134531A1/en active Pending
- 2020-03-16 SG SG11202110423UA patent/SG11202110423UA/en unknown
- 2020-03-16 KR KR1020217034148A patent/KR20210143254A/ko unknown
-
2021
- 2021-09-23 IL IL286624A patent/IL286624A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3134531A1 (en) | 2020-10-01 |
KR20210143254A (ko) | 2021-11-26 |
JP2022527621A (ja) | 2022-06-02 |
SG11202110423UA (en) | 2021-10-28 |
WO2020197816A1 (en) | 2020-10-01 |
EP3946311A1 (en) | 2022-02-09 |
CN114072139A (zh) | 2022-02-18 |
IL286624A (en) | 2021-10-31 |
EP3946311A4 (en) | 2022-12-28 |
BR112021019039A2 (pt) | 2021-11-30 |
AU2020245203A1 (en) | 2021-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ603345A (en) | Stabilized ophthalmic galactomannan formulations | |
EA025026B1 (ru) | Система подачи невязкого полимерного раствора на основе простагландина, не содержащего консервант | |
RU2017115563A (ru) | Композиции и способы лечения дисфункции мейбомиевых желез | |
RU2010142353A (ru) | Водные фармацевтические композиции, содержащие борат-полиольные комплексы | |
BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
PH12015502542A1 (en) | Stabilized pemetrexed formulation | |
EA202091755A1 (ru) | Композиции гиалуроновой кислоты, включающие мепивакаин | |
MX2016014411A (es) | Formulacion liquida que comprende un compuesto neutralizante de gm-csf. | |
KR20180110113A (ko) | 도르졸라미드와 브리모니딘을 포함하는 의약 조성물 | |
MX2023009052A (es) | Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo. | |
MX2022001021A (es) | Formulacion farmaceutica. | |
MX2021011589A (es) | Composición anestésica y método para anestesiar el ojo. | |
BR112015006464A2 (pt) | composição farmacêutica compreendendo rebamipida | |
EA201591653A1 (ru) | Композиции для лечения глазных расстройств с применением дипиридамола | |
TW201309306A (zh) | 含有玻尿酸或其鹽及丙二醇之點眼液 | |
EA033306B1 (ru) | Стабилизированный раствор на основе активных веществ, способ получения стабилизированного раствора активных веществ, фармацевтическая композиция на основе стабилизированного раствора активных веществ (два варианта) | |
JP5922609B2 (ja) | 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物 | |
BR112023023129A2 (pt) | Composições orais e métodos relacionados para reduzir a irritação da garganta | |
CN102215819B (zh) | 具有相对低的离子强度的药物组合物 | |
MX2022011565A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
JP6877196B2 (ja) | メグルミン又はその塩からなる防腐剤 | |
JP2015086222A (ja) | 安定化された2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物 | |
BR112014013564A2 (pt) | composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz | |
US9050325B2 (en) | Ondansetron nasal spray composition | |
PL434409A1 (pl) | Zastosowanie kompozycji alkaloidów protoberberynowych jako środka antybakteryjnego i antygrzybicznego do stabilizacji kolagenu rybiego oraz sposób stabilizacji kolagenu rybiego |